Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

astrazeneca do brasil ltda - saxagliptina, cloridrato de metformina - antidiabeticos

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

cristÁlia produtos quÍmicos farmacÊuticos ltda. - micofenolato de mofetila - imunosupressor

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

bristol-myers squibb farmacÊutica ltda - sulfato de atazanavir - antiviroticos (inibe replicacao virotica)

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

celltrion healthcare distribuicao de produtos farmaceuticos dos brasil ltda - infliximabe - antinflamatorios

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

vitamedic industria farmaceutica ltda - dicloridrato de flunarizina - vasodilatadores

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

bristol-myers squibb farmacÊutica ltda - antidiabeticos

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

ems sigma pharma ltda - neurolepticos

Europos Sąjunga - portugalų - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - carcinoma, células escamosas - agentes antineoplásicos - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Brazilija - portugalų - ANVISA (Agência Nacional de Vigilância Sanitária)

sanofi medley farmacÊutica ltda. - lactato de milrinona - vasodilatadores

Brazilija - portugalų - CPVS (Compêndio de Produtos Veterinários)

laboratÓrios vencofarma do brasil ltda. - mebendazol; - endoparasiticidas (anti-parasitÁrios)